Evaluation of the antiretroviral efficacy as first line treatment assessed as percentage of patients with viral load below 400 copies/ml at week 48 in the intention to treat (ITT) population S48 [clinicaltrials_resource:99b1b06db7e2add1d66b99af3f9911a0]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Evaluation of the antiretroviral efficacy as first line treatment assessed as percentage of patients with viral load below 400 copies/ml at week 48 in the intention to treat (ITT) population S48 [clinicaltrials_resource:99b1b06db7e2add1d66b99af3f9911a0]
Bio2RDF identifier
99b1b06db7e2add1d66b99af3f9911a0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:99b1b06db7e2add1d66b99af3f9911a0
measure [clinicaltrials_vocabulary:measure]
Evaluation of the antiretrovir ...... tion to treat (ITT) population
time frame [clinicaltrials_vocabulary:time-frame]
identifier
clinicaltrials_resource:99b1b06db7e2add1d66b99af3f9911a0
title
Evaluation of the antiretrovir ...... to treat (ITT) population S48
@en
type
label
Evaluation of the antiretrovir ...... 1b06db7e2add1d66b99af3f9911a0]
@en